Table 1.
Clinical Characteristics | All Uterine Sarcoma (n=80) | Histological Type | |||
---|---|---|---|---|---|
| |||||
ESS n=38, 47.5% | LMS n=22, 27.5% | CS n=18, 22.5% | Undifferentiated Sarcoma n=2, 2.5% | ||
Age, years [mean (range)] | 57.3 (36-87) | 54.2 (36-72) | 55.8 (44-62) | 66.3 (48-87) | 52.5 (50-55) |
Age Range (years) | |||||
40 and below | 2 (2.5%) | 2 | 0 | 0 | 0 |
41-50 | 14 (17.5%) | 7 | 6 | 1 | 0 |
51-60 | 39 (48.75%) | 21 | 11 | 5 | 2 |
61-70 | 21 (26.25%) | 7 | 5 | 9 | 0 |
71-80 | 3 (3.75%) | 1 | 0 | 2 | 0 |
81 and above | 1 (1.25%) | 0 | 0 | 1 | 0 |
Menopause, n (%) | |||||
Pre-menopausal | 24 (30.0%) | 4 (10.5%) | 12 (54.5%) | 8 (44.4%) | 0 (0%) |
Post-menopausal | 56 (70.0%) | 34 (89.5%) | 10 (45.5%) | 10 (55.6%) | 2 (100%) |
Clinical Stages | |||||
I | 34 (42.5%) | 20 (52.6%) | 12 (54.5%) | 2 (11.1%) | 0 (0%) |
II | 6 (7.5%) | 0 (0%) | 2 (9.1%) | 4 (22.2%) | 0 (0%) |
III | 22 (27.5%) | 14 (36.8%) | 0 (0%) | 6 (33.3%) | 2 (100%) |
IV | 18 (22.5%) | 4 (10.5%) | 8 (36.4%) | 6 (33.3%) | 0 (0%) |
Total | 80 | 38 | 22 | 18 | 2 |